Although Gilead Sciences produced meaningful results regarding a lung cancer drug test, the competitive shortfall hurt GILD stock. More
Articles
2022 Rewind: 3 Reasons You Shouldn’t Fear the Bear Market
In the first of four "flashback" articles, let's explore your favorite issue of 2022: why bear markets aren't as bad as you think... and why they are actually a good thing. More
The Top 5 Politicians Citadel’s Ken Griffin Donated To
Unusual Whales has released a report detailing billionaire and hedge fund manager Ken Griffin's donations over the past two years. More
No Chump Change: Trump Made $3.9 Million From His NFT Collection
The success of new Trump NFTs shows that the former President is still wildly successful in milking his political clout for revenue. More
Why Elizabeth Warren Is Right About Tesla (TSLA) Stock
Senator Elizabeth Warren thinks Elon Musk has failed Tesla shareholders. Here's why she's correct about him negatively impacting TSLA stock. More
